Aberrant macrophage cytokine production is a conserved feature among autoimmune-prone mouse strains: Elevated interleukin (IL)-12 and an imbalance in tumor necrosis factor-α and IL-10 define a unique cytokine profile in macrophages from young nonobese diabetic mice

Diabetes

Volumn 49, Issue 7, 2000, Pages 1106-1115

  Alleva, David G ^a   Pavlovich, Ryan P ^a   Grant, Christian ^a   Kaser, Steven B ^a   Beller, David I ^a,b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CD40 ANTIGEN; ENDOTOXIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; PROTEIN P40; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; INSULIN DEPENDENT DIABETES MELLITUS; MACROPHAGE; MACROPHAGE FUNCTION; MOUSE; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TH1 CELL;

EID: 0033939014     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.49.7.1106     Document Type: Article

References (52)

1. Delovitch TL, Singh B: The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD (Review). Immunity 7:727-738, 1997
2. Wicker LS, Todd JA, Peterson LB: Genetic control of autoimmune diabetes in the mouse. Ann Rev Immunol 13:179-200, 1995
3. Katz JD, Benoist C, Mathis D: T helper cell subsets in insulin-dependent diabetes. Science 268:1185-1188, 1995
4. Rabinovitch A, Suarez-Pinzon WL, Sorensen O: Interleukin 12 mRNA expression in islets correlates with β-cell destruction in NOD mice. J Autoimmunity 9:645-651, 1996
5. Von Herrath MG, Oldstone MB: Interferon-γ is essential for destruction of β cells and development of insulin-dependent diabetes mellitus. J Exp Med 185:531-539, 1997
6. Wicker LS, Appel MC, Dotta F, Pressey A, Miller J, DeLarato NH, Fischer PA, Boltz RC Jr, Peterson LB: Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice: the NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes. J Exp Med 176:67-77, 1992
7. Prochazka M, Serreze DV, Worthen SM, Leiter EH: Genetic control of diabetogenesis in NOD/Lt mice: development and analysis of congenic stocks. Diabetes 38:1446-1455, 1989
8. g7 molecules from non-obese diabetic mice are poor peptide binders. J Immunol 156:450-458, 1996
9. Serreze DV, Gaedeke JW, Leiter EH: Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci U S A 90:9625-9629, 1993
10. Serreze DV, Gaskins HR, Leiter EH: Defects in the differentiation and function of antigen presenting cells in NOD/Lt mice. J Immunol 150:2534-2543, 1993
11. Serreze DV, Leiter EH: Defective activation of T suppressor cell function in nonobese diabetic mice: potential relation to cytokine deficiencies. J Immunol 140:3801-3807, 1988
12. Prochazka M, Serreze DV, Frankel WN, Leiter EH: NOR/Lt mice: MHC-matched diabetes-resistant strain for NOD mice. Diabetes 41:98-106, 1992
13. Jacob CO, McDevitt H: Tumour necrosis factor-α in murine autoimmune lupus nephritis. Nature 331:356-358, 1988
14. Jacob CO, Aiso S, Michie SA, McDevitt HO, Ocha-Orbea H: Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-α and IL-1. Proc Natl Acad Sci U S A 87:968-972, 1990
15. Jacob CO, SK Lee, Strassmann G: Mutational analysis of TNF-α gene reveals a regulatory role for the 3′ untranslated region in the genetic predisposition of lupus-tike autoimmune disease. J Immunol 156:3043-3050, 1996
16. + T and B lymphocytes. J Immunol 161:4420-4427, 1998
17. Bazzoni F, Beutler B: Comparative expression of TNF-α alleles from normal and autoimmune MHC haplotypes. J Inflamm 45:106-114, 1995
18. Trinchieri G, Gerosa F: Immunoregulation by interleukin 12. J Leukocyte Biol 59:405-411, 1996
19. Trembleau S, Penna G, Bosi E, Mortara A, Gately MK, Adorini L: Interleukin 12 administration induces T helper type 1 cells and accelerates autoimmune diabetes in NOD mice. J Exp Med 181:817-821, 1995
20. Trembleau S, Germann T, Gately MK, Adorini L: The role of IL-12 in the induction of organ-specific autoimmune diseases. Immunol Today 16:383-386, 1995
21. Trembleau S, Penna G, Gregori S, Gately MK, Adorini L: Deviation of pancreas-infiltrating cells to Th2 by interleukin-12 antagonist administration inhibits autoimmune diabetes. Eur J Immunol 27:2330-2339, 1997
22. Swain SL: T-cell subsets: who does the polarizing? Curr Biol 5:849-851, 1995
23. Hogquist KA, Unanue ER, Chaplin DD: Release of IL-1 from mononuclear phagocytes. J Immunol 147:2181-2186, 1991
24. 1 lupus-prone mice. J Immunol 159:5610-5619, 1997
25. Espevik T, Nissen-Meyer J: A highly sensitive cell line, WEHI-164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J Immunol Methods 95:99-105, 1986
26. Skeen MJ, Miller MA, Shinnick TM, Ziegler HK: Regulation of murine macrophage IL-12 production: activation of macrophages in vivo, restimulation in vitro, and modulation by other cytokines. J Immunol 156:1196-1206, 1996
27. Gordon C, Ranges GE, Greenspan JS, Wofsy D: Chronic therapy with recombinant tumor necrosis factor-α in autoimmune NZB/NZW F1 mice. Clin Immunol Immunopathol 52:421-434, 1989
28. Yang XD, Tisch R, Singer S, Cao Z, Liblau R, Schreiber R, McDevitt H: Effect of tumor necrosis factor α on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process. J Exp Med 180:995-1004, 1994
29. Hartwell D, Levine J, Fenton M, Francis C, Leslie C, Beller D: Cytokine dysregulation and the initiation of systemic autoimmunity. Immunol Lett 43:15-20, 1994
30. Donnelly RP, Levine J, Hartwell DW, Frendl G, Fenton MJ, Beller DI: Aberrant regulation of IL-1 expression in macrophages from young autoimmune-prone mice. J Immunol 145:3231-3239, 1990
31. Levine J, Pugh BJ, Hartwell D, Fitzpatrick JM, Marshak-Rothstein A, Beller DI: Interleukin-1 dysregulation is an intrinsic defect in macrophages from MRL autoimmune-prone mice. Eur J Immunol 23:2951-2958, 1993
32. ++ and NZB/W F1 lupus-prone mice and the Leishmania major-susceptible BALB/c strain. J Immunol 161:6878-6884, 1998
33. Dahlen E, Dawe K, Ohlsson L, Hedlund G: Dendritic cells and macrophages are the first and major producers of TNF-α in pancreatic islets in the nonobese diabetic mouse. J Immunol 160:3585-3593, 1998
34. Pennline KJ, Roquegaffney E, Monahan M: Human IL-10 prevents the onset of diabetes in the NOD mouse. Clin Immunol Immunopathol 71:169-175, 1994
35. Ishida H, Muchamuel T, Sakaguchi S, Andrade S, Menon S, Howard M: Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice. J Exp Med 179:305-310, 1994
36. Cope AP: Regulation of autoimmunity by proinflammatory cytokines (Review). Curr Opin Immunol 10:669-676, 1998
37. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumor necrosis factor. Nature 377:348-351, 1995
38. Rabinovitch A, Suarez-Pinzon WL, Sorensen O, Rajotte RV, Power RF: TNF-α down-regulates type 1 cytokines and prolongs survival of syngeneic islet grafts in nonobese diabetic mice. J Immunol 159:6298-6303, 1997
39. Grewal IS, Grewal KD, Wong FS, Picarella DE, Janeway CA Jr, Flavell RA: Local expression of transgene-encoded TNF-α in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of autoreactive islet-specific T cells. J Exp Med 184:1963-1974, 1996
40. Zubiaga AM, Munoz E, Huber BT: Production of IL-1α by activated Th type 2 cells: its role as an autocrine growth factor. J Immunol 146:3849-3856, 1991
41. Lichtman AH, Chin J, Schmidt JA, Abbas AK: Role of interleukin-1 in the activation of T lymphocytes. Proc Natl Acad Sci U S A 85:9699-9703, 1988
42. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold K, Bluestone JA: Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med 18:1145-1155, 1995
43. Kuchroo VK, Das MP, Brown JA, Ranger AM, Zamvil SS, Sobel RA, Weiner HL, Nabavi N, Glimcher LH: B7.1 and B7.2 costimulatory molecules activate differentially the Th1/Th2 development pathways: application to autoimmune disease therapy. Cell 80:707-718, 1995
44. Bagenstose LM, Salgame P, Monestier M: IL-12 down-regulates autoantibody production in mercury-induced autoimmunity. J Immunol 160:1612-1617, 1998
45. Reiner SL, Locksley RM: The regulation of immunity to Leishmania major. Ann Rev Immunol 13:151-177, 1995
46. Honeyman MC, Stone NL, Harrison LC: T-cell epitopes in type 1 diabetes autoantigen tyrosine phosphatase IA-2: potential for mimicry with rotavirus and other environmental agents. Mol Med 4:231-239, 1998
47. + T-cells in T-cell receptor transgenic NOD mice. Diabetes 48:34-42, 1999
48. Jun HS, Yoon CS, Zbytnuik L, van Rooijen N, Yoon JW: The role of macrophages in T cell-mediated autoimmune diabetes in nonobese diabetic mice. J Exp Med 189:347-358, 1999
49. Trembleau S, Penna G, Gregori S, Chapman HD, Serreze DV, Magram J, Adorini L: Pancreas-infiltrating Th1 cells and diabetes develop in IL-12-deficient nonobese diabetic mice. J Immunol 163:2960-2968, 1999
50. Campbell IL, Kay TW, Oxbrow L, Harrison LC: Essential role for interferon-gamma and interleukin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice. J Clin Invest 87:739-742, 1999
51. Debray-Sachs M, Carnaud C, Boitard C, Cohen H, Gresser I, Bedossa P, Bach JF: Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun 4:237-248, 1991
52. Gerosa F, Paganin C, Peritt D, Paiola F, Scupoli MT, Aste-Amezaga M, Frank I, Trinchieri G: Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10. J Exp Med 183:2559-2569, 1996